10.29.15
Tecomet Inc. has welcomed a new member to its executive management team, hiring Mark Kemp as president and chief operating officer.
Kemp reports to CEO Bill Dow, and is responsible for the operations and commercial areas of Tecomet's global business. Finance and quality personnel will continue to report to Dow.
Kemp’s appointment follows Tecomet’s acquisitions last year of Symmetry Medical’s OEM Solutions business and 3D Medical, creating the world's largest orthopedic contract manufacturer, with facilities located in five countries on three continents.
“We are very pleased to have Mark join our team and are excited about the customer focused global supply side experience that he will provide in his leadership role as we continue integrating our sites and implementing our operational strategy,” Dow in a news release announcing Kemp's appointment.
Kemp brings to his position valuable experience in end-to-end supply chain solutions, having had an extensive career with Flextronics International Ltd. His most recent position was president of Flextronics Medical. Kemp has more than 20 years of experience in the engineered manufacturing solutions industry and holds a bachelor of science degree in Mechanical Engineering from the University of Florida as well as a masters of Business Administration in Aviation from Embry-Riddle Aeronautical University in Daytona Beach, Fla. He has served in various executive capacities including operations, business development, account management, materials and program management, and marketing/communications.
“Tecomet has a very talented team,” Kemp said. “I am very excited about joining the Tecomet team and the opportunity to help expand the breadth of services that we provide to our customers globally.”
“We are excited about the addition of an executive with Mark’s stature and experience to the already strong Tecomet senior management team to help guide future expansion,” added Rob Rutledge, managing director of Genstar Capital, which invested in Tecomet in December 2013.
Founded in 1964 and based in Wilmington, Mass., Tecomet manufactures orthopedic implants, precision surgical instruments, trauma plates and photochemical etched products.
Genstar Capital is a San Francisco, Calif.-based private equity investment firm that funds businesses in the healthcare, software, industrial technology and financial services industries. Its capital commitments total more than $5 billion.
Kemp reports to CEO Bill Dow, and is responsible for the operations and commercial areas of Tecomet's global business. Finance and quality personnel will continue to report to Dow.
Kemp’s appointment follows Tecomet’s acquisitions last year of Symmetry Medical’s OEM Solutions business and 3D Medical, creating the world's largest orthopedic contract manufacturer, with facilities located in five countries on three continents.
“We are very pleased to have Mark join our team and are excited about the customer focused global supply side experience that he will provide in his leadership role as we continue integrating our sites and implementing our operational strategy,” Dow in a news release announcing Kemp's appointment.
Kemp brings to his position valuable experience in end-to-end supply chain solutions, having had an extensive career with Flextronics International Ltd. His most recent position was president of Flextronics Medical. Kemp has more than 20 years of experience in the engineered manufacturing solutions industry and holds a bachelor of science degree in Mechanical Engineering from the University of Florida as well as a masters of Business Administration in Aviation from Embry-Riddle Aeronautical University in Daytona Beach, Fla. He has served in various executive capacities including operations, business development, account management, materials and program management, and marketing/communications.
“Tecomet has a very talented team,” Kemp said. “I am very excited about joining the Tecomet team and the opportunity to help expand the breadth of services that we provide to our customers globally.”
“We are excited about the addition of an executive with Mark’s stature and experience to the already strong Tecomet senior management team to help guide future expansion,” added Rob Rutledge, managing director of Genstar Capital, which invested in Tecomet in December 2013.
Founded in 1964 and based in Wilmington, Mass., Tecomet manufactures orthopedic implants, precision surgical instruments, trauma plates and photochemical etched products.
Genstar Capital is a San Francisco, Calif.-based private equity investment firm that funds businesses in the healthcare, software, industrial technology and financial services industries. Its capital commitments total more than $5 billion.